BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36171605)

  • 21. Early increase of peripheral B cell levels in kidney transplant recipients with CMV infection or reactivation.
    Besançon-Watelet C; De March AK; Renoult E; Kessler M; Béné MC; Faure GC; Sarda MN
    Transplantation; 2000 Feb; 69(3):366-71. PubMed ID: 10706044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of cytomegalovirus infection in France in 2010.
    Antona D; Lepoutre A; Fonteneau L; Baudon C; Halftermeyer-Zhou F; LE Strat Y; Lévy-Bruhl D
    Epidemiol Infect; 2017 May; 145(7):1471-1478. PubMed ID: 28166842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis.
    Zuhair M; Smit GSA; Wallis G; Jabbar F; Smith C; Devleesschauwer B; Griffiths P
    Rev Med Virol; 2019 May; 29(3):e2034. PubMed ID: 30706584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis.
    Döcke WD; Kiessling C; Worm M; Friedrich M; Pruss A; Weitz M; Prösch S; Kern F; Volk HD; Sterry W; Asadullah K
    Br J Dermatol; 2003 May; 148(5):954-63. PubMed ID: 12786826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.
    Staras SA; Dollard SC; Radford KW; Flanders WD; Pass RF; Cannon MJ
    Clin Infect Dis; 2006 Nov; 43(9):1143-51. PubMed ID: 17029132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development.
    Fowler K; Mucha J; Neumann M; Lewandowski W; Kaczanowska M; Grys M; Schmidt E; Natenshon A; Talarico C; Buck PO; Diaz-Decaro J
    BMC Public Health; 2022 Sep; 22(1):1659. PubMed ID: 36050659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological and Liver Biomarkers Profile of Epstein-Barr Virus Infection and Its Coinfection with Cytomegalovirus in Patients with Hematological Diseases.
    Ferrari de Freitas L; de Melo Silva J; Nogueira Barbosa A; Miranda Santos E; Pinheiro-Silva R; Soares Pontes G
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children's patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study.
    Ruan Y; Luo T; Liu Q; Liu X; Chen L; Wen J; Xiao Y; Xie D; He Y; Wu X; Feng X
    Front Cell Infect Microbiol; 2022; 12():1027341. PubMed ID: 36339340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J; Rotjanapan P; Watcharananan SP
    Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of Cytomegalovirus among pregnant women in Africa.
    Mhandire D; Rowland-Jones S; Mhandire K; Kaba M; Dandara C
    J Infect Dev Ctries; 2019 Oct; 13(10):865-876. PubMed ID: 32084016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus: its potential role in the development of cutaneous T-cell lymphoma.
    Ballanger F; Bressollette C; Volteau C; Planche L; Dreno B
    Exp Dermatol; 2009 Jun; 18(6):574-6. PubMed ID: 19320742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.
    Al-Hajjar S; Al Seraihi A; Al Muhsen S; Ayas M; Al Jumaah S; Al Jefri A; Shoukri M; El Solh H
    Hematol Oncol Stem Cell Ther; 2011; 4(2):67-72. PubMed ID: 21727767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
    Liu YC; Lu PL; Hsiao HH; Chang CS; Liu TC; Yang WC; Lin SF
    Ann Hematol; 2012 Apr; 91(4):587-95. PubMed ID: 21997849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications.
    Korndewal MJ; Mollema L; Tcherniaeva I; van der Klis F; Kroes AC; Oudesluys-Murphy AM; Vossen AC; de Melker HE
    J Clin Virol; 2015 Feb; 63():53-8. PubMed ID: 25600606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study.
    Taniguchi K; Watanabe N; Sato A; Jwa SC; Suzuki T; Yamanobe Y; Sago H; Kozuka K
    J Clin Virol; 2014 Mar; 59(3):192-4. PubMed ID: 24468011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of cytomegalovirus IgG antibodies among pregnant women in Japan from 2009-2014.
    Shigemi D; Yamaguchi S; Otsuka T; Kamoi S; Takeshita T
    Am J Infect Control; 2015 Nov; 43(11):1218-21. PubMed ID: 26277571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of cytomegalovirus infection in non-transplant pediatric acute lymphoblastic leukemia patients during chemotherapy.
    Phasuk N; Keatkla J; Rattanasiri S; Techasaensiri C; Anurathapan U; Apiwattanakul N
    Medicine (Baltimore); 2019 Jan; 98(4):e14256. PubMed ID: 30681620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent infections and their relationship with selected oncologic and non-tumor pathologies.
    Chumak AA; Abramenko IV; Bilous NI; Filonenko IA; Kostin OV; Pleskach OY; Pleskach GV; Efremova N; Yanko J
    J Immunotoxicol; 2010; 7(4):279-88. PubMed ID: 20518708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.